However, although there is strong evidence linking PGC-1 coactivators to HCC pathogenesis, it still remains unclear how this family of coactivators directly affects cancer cell biology and tumor development, particularly when metabolism is altered as in obesity or metabolic disease. Here, PPARGC1A is linked to obesity disorder.